Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 10.79%819.88M | ---- | -16.50%740.04M | ---- | -36.78%886.25M | ---- | 74.12%1.4B | ---- | -25.58%805.09M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | ---- | ---- | ---25.46M | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 72.44%-2.16M | ---- | -4,028.42%-7.84M | ---- | -100.43%-190K | ---- | 209.71%44.19M | ---- | 72.64%14.27M |
| Impairment and provisions: | ---- | -58.19%38.42M | ---- | 158.09%91.9M | ---- | -31.09%35.61M | ---- | -59.75%51.67M | ---- | 1,634.63%128.4M |
| -Impairmen of inventory (reversal) | ---- | -29.60%45.26M | ---- | 29.68%64.29M | ---- | 38.31%49.58M | ---- | 71.00%35.85M | ---- | 264.87%20.96M |
| -Impairment of trade receivables (reversal) | ---- | -689.16%-6.84M | ---- | 93.79%-867K | ---- | -188.27%-13.97M | ---- | 135.01%15.83M | ---- | 306.46%6.74M |
| -Other impairments and provisions | ---- | ---- | ---- | --28.47M | ---- | ---- | ---- | ---- | ---- | --100.7M |
| Revaluation surplus: | ---- | -64.25%266.25M | ---- | 758.48%744.82M | ---- | 83.78%-113.11M | ---- | -50.18%-697.31M | ---- | -2,194.24%-464.31M |
| -Other fair value changes | ---- | -64.25%266.25M | ---- | 758.48%744.82M | ---- | 83.78%-113.11M | ---- | -50.18%-697.31M | ---- | -2,194.24%-464.31M |
| Asset sale loss (gain): | ---- | 100.19%1.5M | ---- | -7,591.48%-791.92M | ---- | 102.63%10.57M | ---- | -5,519.44%-402.02M | ---- | -305.40%-7.15M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---789.49M | ---- | ---- | ---- | -3,697.72%-399.33M | ---- | ---10.52M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 59.56%-984K | ---- | -123.02%-2.43M | ---- | 493.71%10.57M | ---- | -179.89%-2.69M | ---- | -3.50%3.36M |
| -Loss (gain) from selling other assets | ---- | --2.49M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | 9.06%337.65M | ---- | 9.15%309.59M | ---- | 12.64%283.65M | ---- | 13.26%251.81M | ---- | 36.81%222.33M |
| -Amortization of intangible assets | ---- | 103.79%36.86M | ---- | 20.70%18.09M | ---- | -13.96%14.99M | ---- | 0.33%17.42M | ---- | 11.45%17.36M |
| Financial expense | ---- | 248.74%30.33M | ---- | ---20.39M | ---- | ---- | ---- | -97.62%2.56M | ---- | 32.32%107.48M |
| Exchange Loss (gain) | ---- | -58.51%1.53M | ---- | -92.87%3.69M | ---- | 151.36%51.75M | ---- | -1,092.35%-100.76M | ---- | 918.46%10.15M |
| Special items | ---- | 707.08%97.81M | ---- | -91.24%12.12M | ---- | 121.23%138.29M | ---- | 3,263.51%62.51M | ---- | -164.22%-1.98M |
| Operating profit before the change of operating capital | ---- | 47.06%1.59B | ---- | -14.63%1.08B | ---- | 106.26%1.27B | ---- | -24.54%614.45M | ---- | -38.71%814.28M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 93.41%-24.83M | ---- | -221.94%-376.64M | ---- | -1,304.47%-116.99M | ---- | 76.51%-8.33M | ---- | -76.86%-35.46M |
| Accounts receivable (increase)decrease | ---- | 79.19%-61.37M | ---- | -491.86%-294.85M | ---- | 113.80%75.24M | ---- | -0.56%-545.2M | ---- | -40.31%-542.15M |
| Accounts payable increase (decrease) | ---- | 31.79%-65.26M | ---- | -158.13%-95.68M | ---- | -38.63%164.59M | ---- | 3,136.70%268.19M | ---- | -93.18%8.29M |
| prepayments (increase)decrease | ---- | 150.00%76.8M | ---- | -952.75%-153.58M | ---- | 96.97%-14.59M | ---- | -36,061.37%-482.24M | ---- | 103.37%1.34M |
| Special items for working capital changes | ---- | -60,416.67%-10.89M | ---- | 99.94%-18K | ---- | 16.19%-28.62M | ---- | -768.53%-34.14M | ---- | -84.91%5.11M |
| Cash from business operations | 19.28%1.08B | 833.85%1.51B | 1,366.54%906.4M | -88.03%161.23M | -110.70%-71.57M | 819.28%1.35B | 229.01%668.57M | -174.49%-187.27M | -514.14%-518.23M | -75.77%251.4M |
| Other taxs | -390.67%-214.6M | -1,024.81%-114.54M | -321.72%-43.74M | -243.50%-10.18M | -163.14%-10.37M | 148.27%7.1M | 456.93%16.43M | 90.50%-14.7M | 96.79%-4.6M | 41.60%-154.67M |
| Net cash from operations | 0.45%866.53M | 820.98%1.39B | 1,152.84%862.66M | -88.85%151.05M | -111.96%-81.94M | 770.45%1.35B | 231.02%685M | -308.80%-201.97M | -129.66%-522.83M | -87.48%96.73M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -64.78%38.12M | ---- | 53.28%108.23M | ---- | 166.96%70.61M | ---- | 1.27%26.45M | ---- | -76.24%26.12M |
| Dividend received - investment | ---- | -68.64%64.68M | ---- | 5.27%206.26M | ---- | -32.31%195.93M | ---- | 352.15%289.43M | ---- | 4,469.02%64.01M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---100M | ---- | ---- | ---- | --445.83M | --445.83M | ---- |
| Decrease in deposits (increase) | 96.55%-10M | -153.88%-456.54M | -132.22%-290M | 21.06%847.39M | 28.57%900M | 168.62%700M | 168.76%700M | ---1.02B | ---1.02B | ---- |
| Sale of fixed assets | ---- | -57.67%50.09M | ---- | 43,238.46%118.31M | ---- | -95.38%273K | ---- | 530.98%5.91M | ---- | -70.72%936K |
| Purchase of fixed assets | ---- | 22.18%-762.57M | ---- | -185.83%-979.86M | ---- | -63.64%-342.82M | ---- | 40.63%-209.49M | ---- | 30.50%-352.84M |
| Purchase of intangible assets | 80.96%-16.99M | ---- | 58.16%-89.22M | ---- | -69.96%-213.26M | ---335.19M | ---125.47M | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | -96.57%34.11M | ---- | --993.52M | --943.52M | ---- | ---- | -17.50%97.7M | ---- | --118.42M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---87.32M | ---- | ---- | ---- | -3,116.09%-53.05M | ---- | 101.14%1.76M |
| Recovery of cash from investments | -92.70%2.67M | 59.12%79.18M | --36.55M | -47.23%49.76M | ---- | -79.10%94.29M | ---- | -41.00%451.12M | -99.95%315K | -21.56%764.57M |
| Cash on investment | 60.71%-14.35M | -41.86%-97.15M | -84.25%-36.53M | 78.24%-68.49M | 83.81%-19.82M | 32.93%-314.79M | -62.20%-122.45M | -352.26%-469.32M | ---75.49M | 93.79%-103.77M |
| Other items in the investment business | -214.90%-71.68M | ---- | 91.19%-22.76M | ---- | -655.82%-258.33M | ---- | 79.42%46.48M | ---- | 118.28%25.91M | -94.06%9.89M |
| Net cash from investment operations | 72.55%-110.35M | -196.53%-1.05B | -129.73%-401.96M | 1,492.55%1.09B | 171.20%1.35B | 115.68%68.31M | 180.23%498.56M | -182.31%-435.5M | -225.25%-621.44M | 189.23%529.08M |
| Net cash before financing | 64.14%756.19M | -72.47%341.02M | -63.73%460.7M | -12.90%1.24B | 7.32%1.27B | 323.13%1.42B | 203.43%1.18B | -201.86%-637.47M | -526.15%-1.14B | 247.92%625.81M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 5.43%1.05B | 3.04%1.25B | 60.65%996.02M | 32.59%1.22B | 12.73%620M | -10.73%916.93M | 2.34%550M | -50.90%1.03B | -65.21%537.41M | -20.07%2.09B |
| Refund | 13.45%-1.05B | -10.12%-1.41B | -21.37%-1.21B | -8.47%-1.28B | -28.68%-1B | 51.94%-1.18B | 51.87%-777.38M | -35.01%-2.46B | -88.26%-1.62B | 9.90%-1.82B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.12B |
| Interest paid - financing | ---- | 13.21%-30.79M | ---- | -18.31%-35.47M | ---- | 57.68%-29.98M | ---- | 49.82%-70.85M | ---- | 4.81%-141.18M |
| Dividends paid - financing | ---- | 4.23%-401.48M | ---- | -7.14%-419.22M | ---- | 0.00%-391.3M | ---- | ---391.3M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | -138.00%-687.99M | ---- | ---289.07M | ---- | ---- | ---- | ---- | ---- | ---117.3M |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 150.45%315.6M | 151.48%315.6M | -595.11%-625.6M |
| Other items of the financing business | -105.21%-26.31M | --964.98M | 584.87%504.57M | ---- | -57.52%-104.06M | ---16.03M | 6.57%-66.07M | ---- | 29.68%-70.71M | 73.37%-112.03M |
| Net cash from financing operations | -109.41%-26.96M | 54.47%-407.4M | 159.16%286.53M | -18.73%-894.83M | -65.06%-484.36M | 53.61%-753.68M | 64.77%-293.45M | -169.02%-1.62B | -3,007.64%-833M | 332.35%2.35B |
| Effect of rate | -400.68%-1.78M | -52.66%2.29M | -80.19%592K | -68.07%4.83M | 67.58%2.99M | 143.09%15.12M | 121.30%1.78M | 45.16%-35.1M | -1,299.83%-8.37M | -27,685.78%-64M |
| Net Cash | -2.41%729.23M | -119.30%-66.38M | -4.91%747.23M | -48.56%344.02M | -11.72%785.8M | 129.56%668.72M | 145.02%890.11M | -175.92%-2.26B | -918.04%-1.98B | 457.64%2.98B |
| Begining period cash | -3.19%1.94B | 21.04%2.01B | 21.04%2.01B | 70.18%1.66B | 70.41%1.66B | -70.20%974.46M | -70.24%973.14M | 821.70%3.27B | 821.70%3.27B | -70.13%354.8M |
| Cash at the end | -3.07%2.67B | -3.19%1.94B | 12.58%2.75B | 21.04%2.01B | 31.21%2.45B | 70.41%1.66B | 45.18%1.87B | -70.24%973.14M | 115.57%1.28B | 821.70%3.27B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | PwC accounting firm | -- | PwC accounting firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.